Health Care & Life Sciences » Pharmaceuticals | Daewon Pharmaceutical Co. Ltd.

Daewon Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
158,879
181,985
216,187
240,722
265,462
286,653
Cost of Goods Sold (COGS) incl. D&A
70,821
77,650
94,320
97,492
106,470
111,369
Gross Income
88,058
104,335
121,867
143,230
158,993
175,284
SG&A Expense
72,514
86,534
99,062
112,117
132,104
144,696
EBIT
15,544
17,800
22,805
29,148
25,197
30,587
Unusual Expense
879
458
225
1,758
1,296
78
Non Operating Income/Expense
314
3,142
276
30
663
357
Interest Expense
126
100
26
-
151
89
Pretax Income
15,602
21,124
23,247
27,645
23,525
31,210
Income Tax
3,369
5,527
5,913
8,028
13,250
7,924
Equity in Affiliates
-
-
-
106
-
-
Consolidated Net Income
12,233
15,597
17,333
19,723
10,275
23,286
Net Income
12,321
15,729
17,695
20,242
10,742
23,744
Net Income After Extraordinaries
12,321
15,729
17,695
20,242
10,742
23,744
Net Income Available to Common
12,321
15,729
17,695
20,242
10,742
23,744
EPS (Basic)
651.40
829.31
933.62
1,071.66
571.43
1,226.21
Basic Shares Outstanding
19
19
19
19
19
19
EPS (Diluted)
651.69
829.70
933.48
1,071.60
571.25
1,226.05
Diluted Shares Outstanding
19
19
19
19
19
19
EBITDA
19,586
22,126
28,784
36,617
33,896
40,986
Other Operating Expense
-
-
-
1,966
1,692
-
Non-Operating Interest Income
750
740
418
225
224
235
Minority Interest Expense
88
131
361
519
467
458
Equity in Affiliates (Pretax)
-
-
-
-
213
198

About Daewon Pharmaceutical Co.

View Profile
Address
386 Cheonho-daero
Seoul SL 04808
Korea, Republic Of
Employees -
Website http://www.daewonpharm.com
Updated 07/08/2019
Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. It offers multivitamins, antipyretics, analgesics and antiinflammatory, gastrointestinal, endocrine, antimicrobial, psychoneurotic, respiratory, cardiovascular and neuromuscular drugs. The company was founded by Baek Boo-Hyeon on August 9, 1961 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.